Andrew Pavelyev

480 total citations
24 papers, 108 citations indexed

About

Andrew Pavelyev is a scholar working on Epidemiology, Health and Surgery. According to data from OpenAlex, Andrew Pavelyev has authored 24 papers receiving a total of 108 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 12 papers in Health and 4 papers in Surgery. Recurrent topics in Andrew Pavelyev's work include Cervical Cancer and HPV Research (18 papers), Vaccine Coverage and Hesitancy (12 papers) and Hepatitis B Virus Studies (11 papers). Andrew Pavelyev is often cited by papers focused on Cervical Cancer and HPV Research (18 papers), Vaccine Coverage and Hesitancy (12 papers) and Hepatitis B Virus Studies (11 papers). Andrew Pavelyev collaborates with scholars based in United States, Japan and Brazil. Andrew Pavelyev's co-authors include Aurélie Schmidt, Kunal Saxena, Xavier Bresse, Vincent Daniels, S K Tay, Elamin H. Elbasha, L. Lévy-Bachelot, Tak Hong Cheung, Nipon Khemapech and Smita Kothari and has published in prestigious journals such as PLoS ONE, BMC Public Health and Vaccine.

In The Last Decade

Andrew Pavelyev

21 papers receiving 107 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Pavelyev United States 8 94 43 35 14 6 24 108
Vinh Tran United States 4 96 1.0× 64 1.5× 26 0.7× 12 0.9× 12 2.0× 5 129
Katja Harjula Finland 4 102 1.1× 14 0.3× 46 1.3× 11 0.8× 13 2.2× 7 115
Julius Timbol United States 5 99 1.1× 15 0.3× 24 0.7× 4 0.3× 4 0.7× 13 116
Hella Pasmans Netherlands 7 91 1.0× 6 0.1× 46 1.3× 14 1.0× 21 3.5× 8 97
Kamille Fogh Denmark 7 54 0.6× 15 0.3× 47 1.3× 6 0.4× 6 1.0× 12 140
Vesta Richardson López-Collada Mexico 2 36 0.4× 14 0.3× 11 0.3× 3 0.2× 4 0.7× 6 41
Jorge Leon-Cruz United States 2 93 1.0× 4 0.1× 63 1.8× 18 1.3× 4 0.7× 2 105
Galina Minkina Russia 3 55 0.6× 6 0.1× 14 0.4× 21 1.5× 5 0.8× 5 65
Runa Watkins United States 4 40 0.4× 23 0.5× 34 1.0× 9 0.6× 14 2.3× 10 122
Akinfolarin Adepiti Nigeria 4 155 1.6× 4 0.1× 69 2.0× 56 4.0× 7 1.2× 5 164

Countries citing papers authored by Andrew Pavelyev

Since Specialization
Citations

This map shows the geographic impact of Andrew Pavelyev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Pavelyev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Pavelyev more than expected).

Fields of papers citing papers by Andrew Pavelyev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Pavelyev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Pavelyev. The network helps show where Andrew Pavelyev may publish in the future.

Co-authorship network of co-authors of Andrew Pavelyev

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Pavelyev. A scholar is included among the top collaborators of Andrew Pavelyev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Pavelyev. Andrew Pavelyev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Connolly, Mark P., et al.. (2025). Increasing HPV vaccination coverage in Switzerland: a return-on-investment analysis. Journal of Medical Economics. 28(1). 1168–1182.
2.
Jakubczyk, Michał, et al.. (2024). Cost-effectiveness of nonavalent vs bivalent HPV vaccine in Polish setting. Ginekologia Polska. 96(2). 119–125. 1 indexed citations
3.
Pavelyev, Andrew, et al.. (2023). Clinical and economic impact of school-based nonavalent human papillomavirus vaccination in females in Malaysia. Singapore Medical Journal. 67(Suppl 2). S94–S100.
4.
5.
Cheung, Tak Hong, et al.. (2023). Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong. Human Vaccines & Immunotherapeutics. 19(2). 2184605–2184605. 9 indexed citations
6.
Pavelyev, Andrew, Vincent Daniels, S Malhan, et al.. (2023). EE286 Cost Effectiveness and Public Health Impact of Implementing Gender-Neutral Vaccination with the 9-Valent Human Papillomavirus Vaccine in Turkiye. Value in Health. 26(12). S106–S106. 1 indexed citations
7.
Pavelyev, Andrew, et al.. (2022). EE385 Cost Effectiveness of Gender-Neutral Vaccination With Gardasil 9 Against HPV in Greece. Value in Health. 25(12). S131–S131. 1 indexed citations
8.
Chou, Hung‐Hsueh, et al.. (2022). The Clinical and Economic Impact of a Nonavalent Versus Bivalent Human Papillomavirus National Vaccination Program in Taiwan. Value in Health Regional Issues. 32. 79–87. 2 indexed citations
9.
Varga, Štefan, et al.. (2022). POSB149 Health Impact and Cost-Effectiveness Analysis of 9-Valent Versus Bivalent HPV National Immunization Strategies in Singapore. Value in Health. 25(1). S89–S89. 1 indexed citations
10.
Pavelyev, Andrew, et al.. (2022). EE329 Public Health and Economic Impact of a Gender-Neutral Quadrivalent Human Papillomavirus Vaccination Program in El Salvador. Value in Health. 25(12). S119–S119. 1 indexed citations
11.
Termrungruanglert, Wichai, et al.. (2021). The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand. PLoS ONE. 16(2). e0245894–e0245894. 12 indexed citations
12.
Simoens, Steven, et al.. (2021). Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in Belgium. Frontiers in Pharmacology. 12. 628434–628434. 8 indexed citations
13.
Cheung, Tak Hong, Danny Hsu, Queenie Wing-Lei Wong, et al.. (2021). The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong. Cost Effectiveness and Resource Allocation. 19(1). 75–75. 7 indexed citations
14.
15.
16.
17.
Alvis-Zakzuk, Nelson J, Mary Rojas, Andrew Pavelyev, et al.. (2019). PIN9 PUBLIC HEALTH AND ECONOMIC IMPACT OF A GENDER-NEUTRAL QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN COLOMBIA. Value in Health Regional Issues. 19. S41–S42. 1 indexed citations
18.
Pavelyev, Andrew, et al.. (2019). PIN10 PUBLIC HEALTH AND ECONOMIC IMPACT OF A HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM FOR FEMALES AGED 9 YEARS IN EL SALVADOR. Value in Health Regional Issues. 19. S42–S42. 1 indexed citations
19.
20.
Blas, Magaly M., et al.. (2017). The Cost-Effectiveness of Varicella Vaccination In Peru. Value in Health. 20(9). A942–A942. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vinh Tran Breakdown of academic impact, for papers by Katja Harjula Breakdown of academic impact, for papers by Julius Timbol Breakdown of academic impact, for papers by Hella Pasmans Breakdown of academic impact, for papers by Kamille Fogh Breakdown of academic impact, for papers by Vesta Richardson López-Collada Breakdown of academic impact, for papers by Jorge Leon-Cruz Breakdown of academic impact, for papers by Galina Minkina Breakdown of academic impact, for papers by Runa Watkins Breakdown of academic impact, for papers by Akinfolarin Adepiti
Rankless by CCL
2026